-
18AugustIn 2020 in the middle of the pandemic Angela, who had been diagnosed with secondary breast cancer the previous year, completed the 2.6 challenge by walking for 26 miles on her old cross trainer. Two years later her son John … Continue reading
-
06JuneJust three weeks after finishing in the Brighton Marathon Superhero Tim completed the London Marathon. Marathons, skydiving, fitness challenges… there seems no end to the adventures Tim undertakes to raise money for Secondary1st. He is one of our all-time superheroes.
-
06JuneA team of scientists at King’s College London has developed an Artificial Intelligence model which analyses immune responses in the lymph nodes to predict the likelihood of developing secondary breast cancer for patients with triple negative breast cancer. Lymph nodes … Continue reading
-
18AprilLast year Nolan rode a zipwire to raise money for Secondary1st. This year he’s planning to undertake a more down to earth challenge. In September he will cycle more than 1000 km, riding all the way from Land’s End to … Continue reading
-
18AprilNot content with skydiving, running a marathon and organizing a fitness challenge to raise money for Secondary1st our superhero Tim ran in the Brighton Marathon and then after a gap of only three weeks he’s going to run in the London … Continue reading
-
21December
In June 2022 we reported that favourable results from a trial of a new cancer drug, Enhertu (trastuzumab deruxtecan), had been presented at this year’s meeting of the American Society of Clinical Oncology and had been published in the “New … Continue reading
-
21DecemberDr Coffelt and his team at the Beatson Institute for Cancer Research in Glasgow in another project funded by Secondary1st’s fundraisers and donors are working to understand why existing immunotherapies are less effective in treating breast cancer than other cancer … Continue reading
-
21DecemberAt the University of Bradford in one of the projects funded by the wonderful donors and fundraisers of Secondary1st Professor Pors and his PhD student Enrica are continuing their work to improve duocarmycins, a very effective but highly toxic chemotherapy, … Continue reading
-
23NovemberStaff and students from Francis Holland School Regent’s Park put on fancy dress and took part in a sponsored walk around Regent’s Park to raise money for Secondary1st. The weather was ideal to enjoy an autumn afternoon in the open … Continue reading
-
31OctoberIn recently published draft guidance NICE has approved the routine use of another drug combination for some people with secondary breast cancer. Palbociclib, also known as Ibrance, is a targeted drug made by Pfizer and is now recommended in combination … Continue reading
